Equity
€98,516 ▼ 59.4%
IGEA paid out €171,827 in dividends. That is 625% of the 2025 profit.
IGEA
Lifetime
12 annual accounts with figures on one time axispeak €192,219 (2014)
€45,446▲ 44.7%
lowest -€10,153 (2015)
€27,504▲ 74.9%
peak €289,843 (2023)
€98,516▼ 59.4%
€206,213▲ 122%
Board1 name since 2020
1 director
Documentsfilings and deeds
20-08-202620 days late
2025micro format
Gross margin from €31,398 to €45,446Result from €15,725 to €27,504Dividend €171,827Equity from €242,839 to €98,516Debts from €92,896 to €206,213
Key points
from the 2025 annual accountsTurnover
≈ €140,000 estimated
The micro format states no turnover.
Debts
€206,213 ▲ 122%
Debts rose by €113,317 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Investments
€14,536 2.1 × depreciation
Green is investment, beige is depreciation.
Liquidity
1.40 was 3.39 in 2024
Short-term debts rose from €92,896 to €206,213.
Filings
12 annual accounts since 2014
Three of the last ten came late. The 2024 accounts came latest: 60 days after the end of the period.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 34,721 companies had the same profile as IGEA has now. Each dot stands for 87 companies, two years later.
95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,721 companies, not a prediction for IGEA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0535869174
Company renamed from M. CRISTIANI MEDICAL SERVICES to IGEA
Reappointment: (director) · Resignation: (director) · Gazette deed
Registered office moved from lxelles to Waterloo
New registered office: Avenue des Trianons 13, 1410 Waterloo · Previous registered office: Rue du Page 63, 1050 lxelles · holds 100 shares · General meeting of 01-12-2019 · Gazette deed
First establishment
M. CRISTIANI MEDICAL SERVICES, Avenue des Trianons 13, Waterloo
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| IGEA Waterloo | €304,729 | €45,446 | 32.3% | - |
| DR FINK DERMATOLOGIE Ottignies-Louvain-la-Neuve | €264,115 | €48,071 | 24.7% | - |
| JC DUTRANOY Genappe | €256,050 | €47,076 | 41.6% | - |
| DOCTEUR ISABELLE STAS Liège | €336,023 | €44,678 | 43.0% | - |
| CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE Mons | €249,034 | €47,921 | 93.6% | - |
| INAVIUS Tervuren | €300,336 | €39,904 | 65.6% | - |
| Peter Van Dyck Lille | €274,564 | €41,515 | 96.2% | - |
These companies have the same main activity as IGEA: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €249,000 and €336,000, founded between 2009 and 2016.
Official details
Source: KBO- Status
- Active since 21-06-2013Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.298.433.4101410 Waterloo, since 21-01-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 18-12-2025
Insights on IGEA
IGEA files the micro format. That format states no turnover. The gross margin fell from €192,219 in 2014 to €45,446 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about IGEA
- What is the company number of IGEA?
- The company number of IGEA is 0535.869.174. The VAT number is the same number with BE in front: BE 0535.869.174.
- Where is IGEA based?
- The registered office is at Avenue des Trianons 13, 1410 Waterloo.Company details
- What does IGEA do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of IGEA?
- IGEA is a private limited company (BV).
- When was IGEA founded?
- IGEA was founded on 21-06-2013.
- Is IGEA still active?
- Yes, IGEA is an active enterprise in the KBO register.
- What is the turnover of IGEA?
- The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €45,446 and 48 comparable companies (NACE 86). It probably lies between €100,000 and €200,000.Financials
- Is IGEA profitable?
- In financial year 2025, IGEA made a profit of €27,504.
- Where can I find the annual accounts of IGEA?
- IGEA filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of IGEA due?
- IGEA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.